- Corporate Officers - J
- Johnson John
Insider Trading History of Johnson John
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Johnson John since 2019.
This trader's CIK number is 1410781.
At the time of last reporting, Johnson John was the Director of Xeris Biopharma Holdings, Inc.. (stock ticker symbol XERS).
Also see all insider trading activities at Xeris Biopharma Holdings, Inc..
Note that in the past
JOHNSON JOHN also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Xeris Biopharma Holdings, Inc. (XERS) by Johnson John
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | XERS | 0 | $0 | 107,500 | $786,470 | 0 | $0 |
| 2024 | XERS | 0 | $0 | 0 | $0 | 215,600 | $429,044 |
Yearly summary of insider trading at Axogen, Inc. (AXGN) by Johnson John
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | AXGN | 0 | $0 | 4,073 | $43,214 | 0 | $0 |
| 2024 | AXGN | 0 | $0 | 0 | $0 | 11,904 | $0 |
| 2023 | AXGN | 0 | $0 | 0 | $0 | 6,459 | $0 |
Yearly summary of insider trading at Melinta Therapeutics, Inc. /new/ (MLNT) by Johnson John
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | MLNT | 0 | $0 | 13,000 | $72,436 | 50,000 | $0 |
Insider trading activities at 3 companies by Johnson John:
1. Xeris Biopharma Holdings, Inc. (XERS)
2. Axogen, Inc. (AXGN)
3. Melinta Therapeutics, Inc. /new/ (MLNT)
Table 1. Insider trading of Xeris Biopharma Holdings, Inc. (XERS) by Johnson John
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-08-13 | XERS | Sale | 107,500 | 7.32 | 786,470 |
| 2024-03-18 | XERS | Option Ex | 215,600 | 1.99 | 429,044 |
Table 2. Insider trading of Axogen, Inc. (AXGN) by Johnson John
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-06-09 | AXGN | Sale | 4,073 | 10.61 | 43,214 |
| 2024-09-01 | AXGN | Option Ex | 11,904 | .00 | 0 |
| 2023-06-01 | AXGN | Option Ex | 6,459 | .00 | 0 |
Table 3. Insider trading of Melinta Therapeutics, Inc. /new/ (MLNT) by Johnson John
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-06-27 | MLNT | Sale | 13,000 | 5.57 | 72,436 |
| 2019-05-22 | MLNT | Option Ex | 50,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Johnson John
(Director of Xeris Biopharma Holdings, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.